Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.

MLA

Kuhnt, Thomas, et al. “Hyperfractionated Accelerated Radiation Therapy plus Cetuximab plus Cisplatin Chemotherapy in Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck : Final 5‑year Results of a Phase II Study.” Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], vol. 193, no. 9, Sept. 2017, pp. 733–41. EBSCOhost, https://doi.org/10.1007/s00066-017-1145-6.

APA

Kuhnt, T., Schreiber, A., Pirnasch, A., Hautmann, M. G., Hass, P., Sieker, F. P., Engenhart-Cabillic, R., Richter, M., Dellas, K., & Dunst, J. (2017). Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], 193(9), 733–741. https://doi.org/10.1007/s00066-017-1145-6

Chicago

Kuhnt, Thomas, Andreas Schreiber, Anett Pirnasch, Matthias G Hautmann, Peter Hass, Frank P Sieker, Rita Engenhart-Cabillic, Michael Richter, Kathrin Dellas, and Jürgen Dunst. 2017. “Hyperfractionated Accelerated Radiation Therapy plus Cetuximab plus Cisplatin Chemotherapy in Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck : Final 5‑year Results of a Phase II Study.” Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al] 193 (9): 733–41. doi:10.1007/s00066-017-1145-6.